WEKO3
インデックスリンク
アイテム
Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal antigen complementary HLA-mismatched siblings
http://hdl.handle.net/2297/3641
http://hdl.handle.net/2297/364147f56216-14bb-40fd-bf5e-834e6987ec53
名前 / ファイル | ライセンス | アクション |
---|---|---|
ME-PR-OKUMURA-H-797.pdf (149.9 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-10-03 | |||||
タイトル | ||||||
タイトル | Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal antigen complementary HLA-mismatched siblings | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Okumura, Hirokazu
× Okumura, Hirokazu× Yamaguchi, Masaki× Kotani, Takeharu× Sugimori, Naomi× Sugimori, Chiharu× Ozaki, Jun× Kondo, Yukio× Yamazaki, Hirohito× Chuhjo, Tatsuya× Takami, Akiyoshi× Ueda, Mikio× Ohtake, Shigeki× Nakao, Shinji |
|||||
提供者所属 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 金沢大学大学院医学系研究科機能再生学 | |||||
書誌情報 |
European Journal of Haematology 巻 78, 号 2, p. 157-160, 発行日 2007-02-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0902-4441 | |||||
DOI | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1111/j.1600-0609.2006.00797.x | |||||
出版者 | ||||||
出版者 | Elsevier BV | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Human leukocyte antigen (HLA)-mismatched stem cell transplantation from non-inherited maternal antigen (NIMA)-complementary donors is known to produce stable engraftment without inducing severe graft-versus-host disease (GVHD). We treated two patients with acute myeloid leukemia (AML) and one patient with severe aplastic anemia (SAA) with HLA-mismatched stem cell transplantation (SCT) from NIMA-complementary donors (NIMA-mismatched SCT). The presence of donor and recipient-derived blood cells in the peripheral blood of recipient (donor microchimerism) and donor was documented respectively by amplifying NIMA-derived DNA in two of the three patients. Graft rejection occurred in the SAA patient who was conditioned with a fludarabine-based regimen. Grade III and grade IV acute GVHD developed in patients with AML on day 8 and day 11 respectively, and became a direct cause of death in one patient. The findings suggest that intensive conditioning and immunosuppression after stem cell transplantation are needed in NIMA-mismatched SCT even if donor and recipient microchimerisms is detectable in the donor and recipient before SCT. © 2007 The Authors. | |||||
著者版フラグ | ||||||
出版タイプ | AM | |||||
出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa |